Qureshi IA, Mehler MF. Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases. Neurotherapeutics. 2014 Oct;11(4):708-20.

Qureshi IA, Mehler MF. An evolving view of epigenetic complexity in the brain. Philos Trans R Soc Lond B Biol Sci. 2014 Sep 26;369(1652). pii: 20130506.

Qureshi IA, Mehler MF. Developing epigenetic diagnostics and therapeutics for brain disorders. Trends Mol Med. 2013 Dec;19(12):732-41.

Qureshi IA, Mehler MF. Towards a 'systems'-level understanding of the nervous system and its disorders. Trends Neurosci. 2013 Nov;36(11):674-84.

Qureshi IA, Mehler MF. Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics. 2013 Oct;10(4):632-46.

Qureshi IA, Mehler MF. Understanding neurological disease mechanisms in the era of epigenetics. JAMA Neurol. 2013 Jun;70(6):703-10.

Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci. 2012 Jul 20;13(8):528-41.

Qureshi IA, Mehler MF. Non-coding RNA networks underlying cognitive disorders across the lifespan. Trends Mol Med. 2011 Jun;17(6):337-46.

Qureshi IA, Mehler MF. Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke. Transl Stroke Res. 2011 Mar 1;2(1):7-16.

Qureshi IA, Mehler MF. Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility. Prog Brain Res. 2010;186:77-95.

Qureshi IA, Mehler MF. The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine. Arch Neurol. 2011 Mar;68(3):294-302.

Qureshi IA, Mehler MF. The emerging role of epigenetics in stroke: II. RNA regulatory circuitry. Arch Neurol. 2010 Dec;67(12):1435-41.

Qureshi IA, Mehler MF. Emerging role of epigenetics in stroke: I. DNA methylation and chromatin modifications. Arch Neurol. 2010 Nov;67(11):1316-22.

Abrajano JJ, Qureshi IA, Gokhan S, Molero AE, Zheng D, Bergman A, Mehler MF. Corepressor for element-1-silencing transcription factor preferentially mediates gene networks underlying neural stem cell fate decisions. Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16685-90.

Mercer TR, Qureshi IA, Gokhan S, Dinger ME, Li G, Mattick JS, Mehler MF. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neurosci. 2010 Feb 5;11:14.